期刊文献+

C3降低与系统性红斑狼疮患者肾脏及血液活动性升高相关性研究 被引量:4

下载PDF
导出
摘要 目的 :确定C3水平在用 5种方法 (PGA、M SLEDAI、M LAI、SLAM和M BILAG)定义的狼疮活动之前或同时变化的程度 ,以及与狼疮特异性器官活动的相关性。方法 :对随访 1年的 5 3例患者每月检测抗C3水平并判定活动性 ,1个月内PGA≥ 1 0 ,M SLEDAI≥ 3、M LAI≥ 0 1、SLAM≥ 3和M BILAG≥ 4定义为复发 ,计算出C3水平之前变化或同时变化时的复发率 ,用Logistic回归确定C3水平近期变化与狼疮复发的相关性 ,以及与狼疮特异性器官活动的相关性。结果 :根据PGA、M SLEDAI、M LAI、SLAM和M BILAG定义的复发率依次为 12 %、19%、2 5 %、13%和 12 % ,C3水平与 3种方法定义的复发不相关 ,C3水平同时降低常常出现于M LAI定义的复发 ,C3水平之前变化与SLAM确定的复发相关 ,C3水平的同时降低与肾脏活动性计分升高相关。C3水平降低也与红细胞比容、血小板和白细胞同时降低相关 ,C3水平之前降低与血小板降低相关。结论 :补体水平的降低并不一定总是与狼疮活动相关 。
出处 《实用医学杂志》 CAS 2002年第12期1282-1284,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献16

  • 1Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. Clin Exp Rheumatol, 1992, 10(2) :527 ~539.
  • 2Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosusa. Arthritis Rheum, 1997, 40 ( 1 ): 47~ 56.
  • 3Uramoto KM, Michet C J, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950 ~ 1992. Arthritis Rheum, 1999, 42(1 ) :46 ~ 50.
  • 4Barr SG, Zonana-Nacach A, Magder LS, et al. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum, 1999, 42(8):2682 ~ 2688.
  • 5Esdaile JM, Abrahamowicz M, Joseph L, et al. Laboratory test as predictors of disease exacerbations in systemic lupus erythematosus: why some test fail. Arthritis Rheum, 1996, 39(1) :370 ~ 378.
  • 6Swaak AJ, Groenwold J, Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis, 1986, 45(1):359~ 366.
  • 7Petri M, Genovese M, Engle E, et al. Definition, incidence, and clinical description of flare in systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum, 1991, 34(2) :937 ~ 944.
  • 8Bombardier C, Gladman DD, Urowitz MB. Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum, 1992, 35(2) :630~ 640.
  • 9Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activi measures in the routine clinic setting. J Rheumatol, 1992, 19( 1 ) :53~ 59.
  • 10Liang MH, Soeher SA, Larson MG, et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum, 1989, 32(3): 1107 ~ 1118.

同被引文献13

  • 1苏永忠,谢建英,刘元生.以血细胞异常为首发的系统性红斑狼疮临床调查研究[J].临床误诊误治,2004,17(7):490-492. 被引量:3
  • 2Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE)[J].Arthritis Rheum,1982,25(11):1271-1277.
  • 3Cervera R,Khamashta MA,Font J,et al.Morbidity and mortality in systemic lupus erythematosus during a 5-year period.A multicenter prospective study of 1 000 patients.European Working Party on Systemic Lupus Erythematosus[J].Medicine(Baltimore),1999,78(3):167-175.
  • 4叶任高,沈清瑞.肾脏病诊断和治疗学[M].北京:人民卫生出版社,1994:516
  • 5McLaughlin J, Bombardier C, Farewell V, et al. Kidney biopsy in systemic lupus erythematosus HI: survival analysis controlling for clinical and laboratory variables [ J]. Arthritis Rheum, 1994, 37 (4) :559-567.
  • 6Bombardier C, Gladman DD, Urowitz MB, et al. Derivtion of the SLEDAI: a disease activity index for lupus patients [ J ]. Arthritis Rheum, 1992,35(6) :630-640.
  • 7Balow JE, Boumpas DT, Austin HA. Systemic lupus erythematosus [M]. 3rd ed. San Diego: Academic Press, 1999:657-685.
  • 8Balow JE. Clinical presentation and monitoring of lupus nephritis [J]. Lupus, 2005,14(1):25-30.
  • 9张幼莉,张学武,贺联印.系统性红斑狼疮相关性血液学异常[J].临床内科杂志,1998,15(3):160-161. 被引量:28
  • 10陈盛,陈顺乐,顾越英,鲍春德.系统性红斑狼疮患者18年随访[J].中华风湿病学杂志,2000,4(1):27-30. 被引量:57

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部